Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CS-8958 Clinical Pharmacology Study (Intrapulmonary PK in Healthy Japanese Subjects)
jRCT2080221402Phase 1
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of laninamivir in influenza, sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Intrapulmonary pharmacokinetics of CS-8958 and laninamivir.
02
Drugs
laninamivir
03
Conditions
influenza
Beyond the preview
Go deeper on jRCT2080221402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221402.